IGP grant program paused, cutting $5M commercialisation funding for ANZ startups

The federal Industry Growth Program stopped accepting new applications last week, freezing access to grants up to $5 million for startups commercialising products. The pause hits hardware, medtech, and advanced manufacturing companies that rely on non-dilutive capital while they are still building revenue.

IGP grant program paused, cutting $5M commercialisation funding for ANZ startups

IGP paused, no new grant applications

The federal Industry Growth Program (IGP) quietly stopped taking new applications last week while the government reviews the program's future. InnovationAus broke the story: advisers and businesses got notified of the pause, but no public timeline for resumption.

The IGP launched in November 2023 with a $392 million budget over four years. It offered matched grants from $50,000 to $5 million for startups and SMEs commercialising products in priority sectors: clean energy, medtech, advanced manufacturing, defence, agri-value add.

Why this matters for sales hiring

The IGP sat in the "missing middle" of startup funding. Companies too advanced for seed grants, not big enough yet for serious VC rounds. That means businesses with real products but slow-building revenue streams: hardware, deep tech, medical devices.

Those companies use non-dilutive government grants to extend runway while they build sales pipelines. No IGP means shorter runways, which means delayed hiring plans or outright freezes on sales roles.

Eligibility required under $20 million combined annual turnover for the previous three years. That is squarely mid-market territory: companies that would be hiring their first AEs or scaling SDR teams to 3-5 reps.

Market context

This is not happening in isolation. The startup funding environment in 2024 already tightened hiring across ANZ tech. Series A and B rounds took longer to close, valuations compressed, and sales teams got leaner.

Now add a pause to one of the main federal commercialisation funding channels. Companies that were planning to use IGP grants to bridge to revenue milestones are recalculating. Some will push back growth hiring. Others will cut team size to preserve cash.

The government spent budget week promoting new startup tax incentives. Behind the scenes, they froze access to the grants those same startups were counting on to get to market.

What we are watching

How long the pause lasts. Whether the program gets replaced or restructured. And whether the promised tax incentives can actually offset the loss of direct grant funding for commercialisation-stage companies.

For sales professionals: if you are interviewing with a hardware, medtech, or advanced manufacturing startup that mentioned IGP funding in their pitch, ask about runway and Plan B funding. The math just changed.